Why biotech is poised for a recovery this year

wsj
David Wainer, The Wall Street Journal
Photo: ReutersPremium
Photo: Reuters

Pharma and biotech stocks moved in opposite directions last year, but fortunes are shifting

The drug industry is now divided between the haves and the have-nots.